Chemoinformaics analysis of 10,11-(E)-6-Oxo-Dihydroatlantone
Molecular Weight | 234.339 | nRot | 4 |
Heavy Atom Molecular Weight | 212.163 | nRig | 7 |
Exact Molecular Weight | 234.162 | nRing | 1 |
Solubility: LogS | -3.093 | nHRing | 0 |
Solubility: LogP | 3.341 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 41.3234 |
nHD | 0 | BPOL | 23.8066 |
QED | 0.841 |
Synth | 2.729 |
Natural Product Likeliness | 0.824 |
NR-PPAR-gamma | 0.071 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.512 |
Pgp-sub | 0.004 |
HIA | 0.003 |
CACO-2 | -4.589 |
MDCK | 0.0000234 |
BBB | 0.562 |
PPB | 0.886489 |
VDSS | 1.712 |
FU | 0.103049 |
CYP1A2-inh | 0.736 |
CYP1A2-sub | 0.886 |
CYP2c19-inh | 0.881 |
CYP2c19-sub | 0.789 |
CYP2c9-inh | 0.84 |
CYP2c9-sub | 0.963 |
CYP2d6-inh | 0.209 |
CYP2d6-sub | 0.784 |
CYP3a4-inh | 0.391 |
CYP3a4-sub | 0.376 |
CL | 15.6 |
T12 | 0.719 |
hERG | 0.012 |
Ames | 0.037 |
ROA | 0.063 |
SkinSen | 0.167 |
Carcinogencity | 0.156 |
EI | 0.949 |
Respiratory | 0.285 |
NR-Aromatase | 0.022 |
Antiviral | Yes |
Prediction | 0.922737 |